Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Adalimumab with rHuPH20 in RA
NCT00369187Phase 4Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Jul 2006
- Modality
- Therapeutic Enzymes
01
Overview
Phase 4, open-label, single-arm trial of recombinant human hyaluronidase PH20 in rheumatoid arthritis (RA), sponsored by Halozyme Therapeutics, Inc. Primary endpoint: Area Under the Curve. Started Jul 2006; status: completed.
02
Drugs
recombinant human hyaluronidase PH20
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00369187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369187.